2019 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, and Strategic Profiles of Leading Suppliers

2019 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, and Strategic Profiles of Leading Suppliers

  • February 2019 •
  • 280 pages •
  • Report ID: 5438790 •
  • Format: PDF
2019 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, and Strategic Profiles of Leading Suppliers

This 280-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

Contains 280 pages and 6 tables


Companies Profiled
Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher